Publisher： Bentham Science Publishers
E-ISSN： 1873-4286|20|17|2834-2842
ISSN： 1381-6128
Source： Current Pharmaceutical Design, Vol.20, Iss.17, 2014-05, pp. : 2834-2842
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
CD95 Signaling in Cancer Treatment
Current Pharmaceutical Design, Vol. 20, Iss. 17, 2014-05 ,pp. :
Access to resources
Recommend
C-KIT Signaling in Cancer Treatment
Current Pharmaceutical Design, Vol. 20, Iss. 17, 2014-05 ,pp. :
TGF-beta Signaling in Cancer Treatment
Current Pharmaceutical Design, Vol. 20, Iss. 17, 2014-05 ,pp. :
EGFR, HER2 and VEGF Pathways: Validated Targets for Cancer Treatment
Drugs, Vol. 67, Iss. 14, 2007-01 ,pp. :
Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 4, 2012-04 ,pp. :